[Gaucher Disease]
- PMID: 26329151
- DOI: 10.11477/mf.1416200267
[Gaucher Disease]
Abstract
Gaucher disease is an autosomal recessive disorder caused by congenital deficiency of lysosomal glucocerebrosidase. Gaucher disease is classified into three types. In addition to enzyme replacement therapy, substrate reduction therapy, chemical chaperon therapy, and hematopoietic stem cell transplantation therapy are considered for the effective treatment of Gaucher disease.
Similar articles
-
[Molecular diagnosis and gene therapy for Gaucher disease].Nihon Rinsho. 1993 Sep;51(9):2300-7. Nihon Rinsho. 1993. PMID: 8411706 Japanese.
-
[Gaucher's disease: pathogenesis, diagnosis and therapy].Orv Hetil. 2004 Sep 12;145(37):1883-90. Orv Hetil. 2004. PMID: 15493618 Review. Hungarian.
-
[Gaucher disease: A review].Rev Med Interne. 2019 May;40(5):313-322. doi: 10.1016/j.revmed.2018.11.012. Epub 2019 Jan 11. Rev Med Interne. 2019. PMID: 30638965 Review. French.
-
Gaucher Disease: Clinical, Biological and Therapeutic Aspects.Pathobiology. 2016;83(1):13-23. doi: 10.1159/000440865. Epub 2015 Nov 21. Pathobiology. 2016. PMID: 26588331 Review.
-
A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.Dis Model Mech. 2016 Jul 1;9(7):769-78. doi: 10.1242/dmm.024588. Epub 2016 May 19. Dis Model Mech. 2016. PMID: 27482815 Free PMC article.
Cited by
-
A novel mutation causing type 1 Gaucher disease found in a Japanese patient with gastric cancer: A case report.Medicine (Baltimore). 2018 Jul;97(27):e11361. doi: 10.1097/MD.0000000000011361. Medicine (Baltimore). 2018. PMID: 29979419 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical